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Diabetes is a chronic metabolic disorder present in almost all countries. According to WHO, T2DM is the World’s fifth 
leading cause of death. Treatment for T2DM depends on the incretin hormone (GLP-1 & GIP). GLP-1 plays a vital role in 
the body’s metabolism, such as insulin secretion but DPP-IV enzyme inactivates these incretin hormones. Therefore, it 
becomes important to identify DPP-IV inhibitors that act as prospective antidiabetic agents. Synthetic inhibitors like 
vildagliptin, sitagliptin, and saxagliptin are available in the market but they have some undesirable side effects. There are 
several natural plants as well as products that provide safe and effective medication against diabetes by DPP-IV enzyme 
inhibitory mechanism. This review summarizes recent advancement of DPP-IV inhibitors from medicinal plants and isolated 
phytoconstituents including alkaloids, flavonoids, terpenoids, phenol, and stilbenoids which are responsible for the DPP-IV 
inhibition.  
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Introduction 
Diabetes mellitus (DM) is the most common 
metabolic disorders with micro- and macro-vascular 
complications. According to WHO, DM is considered 
as one of the leading causes of death in the world¹. 
Type 2 DM (T2DM) is the common type of this 
disease and responsible for at least 90% cases. 
Although in most patients with T2DM, there may be 
no obvious symptoms for a long period, it still 
threatens human health. Blurred vision, drowsiness, 
weight gain, numbness in hands and feet and gum 
disease are common symptoms of T2DM in patient2,3. 
In the modern system of medicine, no suitable and 
effective therapy is available to cure diabetes mellitus. 
There is a gradual increase in demand to use natural 
products with antidiabetic activity due to side effects 
associated with the use of insulin and oral 
hypoglycemic agent. The most recent medications 
used to treat T2DM are inhibitors of dipeptidyl 
peptidase IV (DPP-IV). 
DPP-IV is an enzyme mainly found in the capillary 
bed of the gut mucosa and other body organs like 
kidney, liver and intestine4. It is widely distributed in 
almost all human cells, tissues and organs. This 
enzyme belongs to the family of serine proteases, 
containing 766 amino acids. This enzyme is known 
for inactivating two incretin hormones glucagon-like 
peptide 1 (GLP-1) and glucose dependent-
insulinotropic polypeptide (GIP)5,6. GLP-1 plays a 
very important role in body metabolism and insulin 
secretion. It also reduces the gastric emptying time 
and gastric acid secretion to reduce postprandial 
glucose spikes6. Administration of DPP-IV inhibitors 
blocks the enzyme (DPP-IV) and thereby enhances 
the half-life and main functional activity of GLP-I. 
One of the recent therapies used in the treatment of 
Type 2 diabetes are synthetic DPP-IV inhibitors7 like 
vildagliptin8, sitagliptin9, and saxagliptin10 but they 
have several side effects, therefore, it is necessary to 
identify natural DPP-IV inhibitors. 
 
Mechanism of DPP-IV action 
It is a well-known fact that glucagon-like peptide-1 
(GLP-1) and glucose-dependent insulin tropic 
polypeptide (GIP) are the two main human incretin 
hormones that stimulate insulin release in the healthy 
individuals11,12.  
Glucagon-like peptide-1 (GLP-1) is produced from 
the proglucagon gene in L-cells of the small intestine. 
GLP-1 has its main effect by stimulating glucose-
dependent insulin release from the pancreatic 
islets12,13. It is responsible to slow down the gastric 
emptying and inhibit inappropriate post-meal 
—————— 
*Correspondent author 
Email: sunilmadhuban@kuk.ac.in, sunilmadhuban@yahoo.com 
INDIAN J NAT PROD RESOUR, DECEMBER 2019 
 
 
228
glucagon release (Fig. 1). It is considered as an 
incretin hormone and is one among the family of 
naturally occurring gut hormones that is released in 
the setting of a meal, but not with intravenous 
carbohydrate, and stimulates insulin synthesis and 
secretion13-15.  
DPP-IV inhibitors are a class of oral antidiabetic 
drugs inhibits the enzyme DPP-IV and therefore, its 
inhibition affects glucose regulation through multiple 
effects16.  
It is expected that herbal medicine can be a good 
option to oral hypoglycemic agents in the treatment of 
T2DM. It has been assumed that more than 1200 
plants have been used to treat diabetes traditionally 
and at least 136 plants have been evaluated to have 
anti-diabetic activities. However, few studies 
indicated that some plants are responsible for DPP-IV 
inhibition in the treatment of diabetes mellitus. 
 
Medicinal plants showing DPP-IV inhibition 
activity 
The use of herbal medicine in the field of diabetes 
is increasing day by day. Herbs are a promising 
therapeutic approach in the treatment of diabetes as 
complementary and alternative medicine. The purpose 
of this review is to give details of medicinal plants 
showing DPP-IV inhibitory activity (Table 1,2). 
 
Apocynum cannabinum L. (Apocynaceae) 
It is commonly known as Indian Hemp, a perennial 
herbaceous plant found in North-Eastern America and 
can be used as antirheumatic, cardiotonic, diaphoretic, 
emetic, expectorant and vermifuge. An active 
compound isoquercetin isolated from the leaves of 
Apocynum cannabinum L. (Apocynaceae) responsible 
for DPP-IV inhibitory activity with an IC50 value  
96.8 µΜ17. 
 
Avena sativa L. (Poaceae) 
It is also known as oats. It has a high protein 
content of about 12.4 to 24.5%. Three peptides mainly 
 
Table 1 — List of plants showing DPP-IV inhibition with their respective IC50 values 
S.No. Name of the plant Common name Family Part of plant used IC50 value Reference 
1 Apocynum cannabinum L. Indian hemp Apocynaceae Leaves 96.8 µM 17 
2 Avena sativa L. Oat Poaceae Seeds 0.99 mg/mL 18 
3 Berberis aristata DC Indian berberry Berberidaceae Bark  14.4 µg/mL 19 
4 Camelia sinensis (L.) Kuntze White tea Theaceae Leaves 227 μg/mL 20 
5 Castanospermum australe A. Cunn. &  
C. Fraser 
Black bean Fabaceae Seeds 13.96 g/mL 21 
6 Cicer arietinum L. Chickpea Leguminosae Leaves and grams 0.09 mg/mL 22 
7 Desmodium gangeticum (L) DC Salparni Leguminosae Aerial parts 255.5 µg/mL 24 
8 Eugenia jambolana Lam. Jamun Myrtaceae Seeds 278.94 µg/mL 25 
9 Fagonia cretica L. Ustarkhar Zygophyllaceae Aerial parts 38.1 μg/mL 26 
10 Fagopyrum esculentum Moench Buckwheat Polygonaceae Seeds 1.98 mg/mL 18 
11 Ferula assa-foetida L. Devil’s dung Apiaceae Seeds 24.5 μg/mL 27 
12 Gymnema sylvestre (Retz.) R. Br. ex Sm Gurmar Asclepiadaceae Leaves 773.22 µg/mL 25 
13 Hedera nepalensis K. Koch Himalayan ivy Araliaceae Aerial parts 17.2 μg/mL 26 
14 Hordeum vulgare var. trifurcatum Barley Poaceae Seeds 1.83 mg/mL 18 
15 Mangifera indica Mango Anacardiaceae Leaves  182.7 μg/mL 28 
16 Morus alba L. White mulberry Moraceae Leaves 480 μg/mL 30 
17 Pilea microphylla (L.) Liebm. Gunpowder Urticaceae Leaves 520.4 µg/mL 31 
18 Psidium guajava L. Guava Myrtaceae Leaves 380 μg/mL 32 
19 Pterocarpus marsupium Roxb. Malabar kino Leguminosae Leaves 273.73 µg/mL 25 
20 Punica Granatum L. Pomegranate Leguminosae Leaves and fruit  0.19 mg/mL 22 
21 Schisandra chinensis (Turcz.) Baill Magnolia-vine Schisandraceae Fruit 10.8 μg/mL 22 
22 Trigonella foenum graceum L. Fenugreek Leguminosae Seed 0.03 mg/mL 22 
23 Urena lobate L. Caesarweed Malvaceae Leaves 1 654.64 µg/mL 34 
 
 
 
 
Fig. 1 — Mechanism of action of DPP-IV inhibitors 
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derived from oats, buckwheat and barley shows in 
vitro DPP-IV activities. All peptides present in oats 
shows enzyme inhibition activities at different 
concentration with a substrate Gly Pro-pNA. It is 
concluded that oats are highly responsible for 
inhibiting DPP-IV enzyme and shows a significant 
level of inhibition with IC50 0.99 mg/mL18. 
 
Berberis aristata DC (Berberidaceae) 
It’s a woody plant, native to the Himalayas in 
India and Nepal. Berberis aristata DC root is used in 
a number of ailments like antibacterial, antiplatelet, 
anti-inflammatory, analgesic, antipyretic, antioxidant 
and hepatoprotective activities etc. Methanolic 
extract of the bark of B. aristata has the potential  
to inhibit DPP-IV enzyme activity (in vitro). The 
crude bark extract had shown the IC50 value of 
14.4µg/mL19. 
 
Camellia sinensis (L.) Kuntze (Theaceae) 
It is an evergreen shrub, natively found in china 
and Southeast Asia comes under Theaceae family. 
Caffeine is the main constituent of Camellia sinensis 
that function as a secondary metabolite. Elya revealed 
that methanolic extract of white tea had DPP-IV enzyme 
inhibition with the highest percentage as compared to 
other plant extracts. The methanolic fraction of the  
C. sinensis has a greater inhibition percentage 
(50.487%), with an IC50 value of 227 μg /mL20. 
 
Castanospermum austral A. Cunn. & C. Fraser (Fabaceae) 
It is commonly known as Black Bean or  
Moreton Bay Chestnut., native to coastal rainforests 
and beaches in Australia. It mainly contains  
three alkaloids castanospermine, 7-deoxy-6-epi-
castanospermine and australine. The extract of 
Castanospermum australe shows good DPP-IV 
inhibitory potential having an IC50 value of 13.96 
g/mL with the standard Diprotin A shows the IC50 
value of 1.543 g/mL21. HPLC analysis of dry powder 
extract contains three main alkaloids Castanospermine 
(RT=10.91), 7-deoxy-6-epi-castanospermine (RT= 
7.04) and australine (RT=21.55)21. 
 
Cicer arietinum L. (Leguminosae) 
Three kinds of traditional Chinese medicine  
from Xinjiang, Trigonella foenum-graecum, Cicer 
arietinum and Punica Granatum found to have anti-
diabetic effects. Research has proved that all three plant 
extracts have potent inhibition effects on DPP-IV, with 
IC50 values of 0.03, 0.09, and 0.19 mg/mL respectively22. 
 
Commiphora mukul (Hook. ex Stocks) Engl. (Burseraceae) 
Commiphora mukul commonly known as Guggul is 
found in western India and is commonly used as a 
valuable herb in Ayurvedic medicine for over  
2500 years. C. mukul is well known for its  
anti-inflammatory, antispasmodic, carminative, 
hypoglycemic, antiseptic, astringent, sedative, 
stomachic, diaphoretic, diuretic, expectorant, thyroid 
stimulant, anthelmintic, antiseptic, demulcent, 
aphrodisiac, lithonotropic, obesity, antidiabetic, 
antihyperlipidemic, and antiosteoarthritic properties. 
The percentage inhibition of C. mukul (92.97±8.45%) 
shows that it is a potent inhibitor of DPP-IV enzyme23. 
 
Desmodium gangeticum (L.) DC (Leguminosae) 
It is a perennial non-climbing herb or shrub widely 
distributed in tropical and sub-tropical habitats and 
particularly abundant in India and used as a medicinal 
herb in indigenous system of medicine (Ayurveda) as 
a bitter tonic, febrifuge, digestive, anti-catarrhal, anti-
emetic and in inflammatory conditions. Aqueous 
extract of Desmodium gangeticum exhibited good 
DPP-IV inhibitory activity at different concentration. 
Extract of D. gangeticum shows maximum percentage 
inhibition 73.21% with an IC50 value of 255.5μg/mL24 
compared with the standard Diprotin A. 
 
Table 2 — Plants showing DPP-IV inhibition with their respective % Inhibition values 
S. No. Name of the plant Common name Family Part of plant used % Inhibition Reference 
1 Camelia sinensis (L.) Kuntze White tea Theaceae Leaves 50.487 20 
2 Commiphora mukul (Hook. ex Stocks) 
Engl. 
Guggul Burseraceae - 92.97±8.45 23 
3 Desmodium gangeticum (L) DC Salparni Leguminosae Aerial parts 73.21 24 
4 Emblica officinalis  Gaertn Amla Phyllanthaceae - 85.95±7.16 23 
5 Momordica charantia L. Bitter gourd Cucurbitaceae Fruits 53.25±0.04 29 
6 Morinda citrifolia L. Indian mulberry Rubiaceae - 24.64±2.24 23 
7 Ocimum sanctum L. Tulsi Lamiaceae Leaves 66.81±0.05 29 
8 Terminalia arjuna (Roxb. ex DC.) 
Wight & Arn. 
Arjuna Combretaceae - 83.39 23 
9 Tinospora crispa (L.) Hook. f. & 
Thomson 
Guduchi Menispermaceae Stem 65.86±1.02 33 
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Emblica officinalis Gaertn. (Phyllanthaceae) 
Emblica officinalis grows in tropical and 
subtropical parts of China, India, and the Malay 
Peninsula. The fruit is commonly known as amla or 
emblic myrobalan. The fruits of E. officinalis have 
been reported to have potent antimicrobial, 
antioxidant, adaptogenic, hepatoprotective, anti-
tumour and antiulcerogenic activities. Manjusha K 
Borde et al., screened five plants extract (Terminalia 
arjuna, Commiphora mukul, Gymnema sylvestre, 
Morinda citrifolia, and E. officinalis) for DPP-IV 
inhibitory activities compared with synthetic 
inhibitors (Vildagliptin and Sitagiptin). However,  
C. mukul, T. arjuna, and E. officinalis extract found  
to be significant DPP-IV inhibitors with inhibition 
percentage 92.97±8.45, 83.39±7.58, and 85.95±7.16% 
respectively23. 
 
Eugenia jambolana Lam. (Myrtaceae) 
It is a berry fruit, which grows abundantly in 
tropical regions of South Asia and South America, 
and is used in traditional medicines such as Ayurveda. 
In vitro assay suggest that Eugenia jambolana 
potently inhibits DPP-IV enzyme with IC50 values of 
278.94 µg/mL25.  
 
Fagonia cretica L. (Zygophyllaceae) 
It is natively found in Malta, Spain, Crete and 
North Africa. It is used in the treatment of general 
debility, mouth ulcer, nausea, vomiting and 
diarrhoea. Mirza B et al. investigated two plants and 
their chemical compounds for the DPP-IV enzyme 
inhibition activity A crude extract of Fagonia cretica 
possessed good inhibitory activity (IC50 value:  
38.1 μg/mL)26. F. cretica contains mainly four 
compounds (1) quinovic acid, (2) quinovic acid-3β-
O-β-D-glycopyranoside, (3) quinovic acid-3β-O-β-
D-glucopyranosyl-(28-1)-β-D-glucopyranosyl ester, 
and (4) stigmasterol. These are also responsible for 
DPP-IV enzyme inhibition with an IC50 value of 
30.7, 57.9, 23.5 and >100 µM respectively. 
 
Fagopyrum esculentum Moench (Polygonaceae) 
It is an annual herb with a green and red stem 
(when mature) also known as buckwheat. Catechins 
and rutin are the main constituents of Fagopyrum 
esculentum. It has been used as an antioxidant, anti-
inflammatory, cardiovascular and hypolipidemic 
agent. Peptides isolated from buckwheat shows in 
vitro inhibitory effects on dipeptidyl peptidase IV 
(DPP-IV) enzyme18. 
Ferula assa-foetida L. (Apiaceae) 
It is also known as asafoetida or devil’s dung and 
comes under the family of Apiaceae. Recent 
pharmacological studies have also shown several 
activities of Ferula assa-foetida, such as antioxidant, 
antiviral, antimicrobial, antispasmodic and 
antidiabetic. Seed extract of F. assa-foetida exhibit 
significant DPP-IV inhibition activities and α-
glucosidase inhibition activities also. Adel yarizade 
estimated potent enzyme inhibitory activity of  
F. assa-foetida fractions27. 
 
Gymnema sylvestre (Retz.) R. Br. ex Sm. (Asclepiadaceae) 
It is found in Central and Western India. Gymnema 
sylvestre (Asclepiadaceae) is a slow-growing, 
perennial, medicinal woody climber found in central 
and peninsular India. It possesses antimicrobial, 
antihypercholesterolemic, hepatoprotective activities. 
Leaves of this plant have been found to cause 
hypoglycemia in laboratory animals and can be used 
in herbal medicine to help, treat adult-onset diabetes 
mellitus (NIDDM). The DPP-IV Inhibitory activity of 
G. sylvestre was calculated as 773.22 µg/mL25. 
 
Hedera nepalensis K. Koch (Araliaceae) 
It is also known as Himalayan ivy, woody climber 
plant up to 30 m long. It is native to Nepal and Bhutan 
as well as China, Afghanistan, India, Laos Thailand 
and Myanmar. Leaves of this plant have been used for 
the treatment of diabetes. A crude extract of Hedera 
nepalensis (HNC) possesses higher inhibitory activity 
with IC50 value: 17.2 μg/mL26. A triterpenoid 
constituent Lupeol of H. nepalensis also shows 
significant DPP-IV inhibitory activity with an IC50 
value of 31.6 μM. 
 
Hordeum vulgare var. trifurcatum L. (Schltdl.) Alef. (Poaceae) 
It is also known as barley and an important 
miscellaneous grain. Barley is mostly known for its 
high amount of dietary fibre such as β-glucan that 
may decrease the risk of coronary heart disease. 
Barley leaves have high antioxidant activity. It has 
been found that the constant consumption of whole 
grains decreased the risk of type 2 diabetes by 31%. 
Peptides isolated from Highland barley known for the 
in vitro DPP-IV inhibitory activity with an IC50 value 
of 1.83 mg/mL18. 
 
Mangifera indica L. (Anacardiaceae) 
It is a popular tree and serves as food and as an 
important medicinal plant. It contains a high amount 
of vitamin A as its main constituent, and also contains 
SHARMA et al.: DPP-IV INHIBITORS FROM NATURAL SOURCES 
 
 
231
vitamin B and C. The methanolic extract of 
Mangifera indica leaves has in vitro DPP-IV 
inhibitory activity. The extract showed potent activity 
with an IC50 value of 182.7 μg/mL28. This plant has 
been reported to have several pharmacological 
activities such as antioxidant, anti-inflammatory, 
antidiabetic, and immune-modulatory activities. 
 
Momordica charantia L. (Cucurbitaceae)  
It is also known as karela or bitter gourd. It is a 
popular plant used for treating diabetes-related 
conditions especially in indigenous populations of 
Asia, South America, India, the Caribbean and East 
Africa. Anand Krishna et al. revealed that the 
methanolic extract of Momordica charantina has 
DPP-IV activities with 53.25±0.04% inhibition29. 
Biochemical and animal model experiments showed 
the antidiabetic effect of M. charantia based on data 
and hypothesis. 
 
Morinda citrifolia L. (Rubiaceae) 
It is also known as Indian mulberry (Noni) is a 
small evergreen tree. The leaves are 8-10 inches long, 
oval-shaped, dark, green and shiny, with deep veins. 
Fruit juice of Morinda citrifolia is a popular health 
drink and possess various pharmacological properties 
including anti-diabetic, antioxidant and anti-
inflammatory. The hydroalcoholic extract of M. 
citrifolia possesses significant inhibition percentage 
(24.64%) for DPP-IV inhibition23.  
 
Morus alba L. (Moraceae) 
It is also known as White mulberry moderately 
fast-growing, deciduous shrub or tree growing 20-35 
meters tall. Its fruit is frequently eaten in various parts 
of the world. Wang et al. showed the antidiabetic 
effect of Traditional Chinese Medicine formula30. 
Both in vitro and in vivo studies were carried out to 
confirm the antidiabetic activity of the formula and 
found that Morus alba leaves extract had potent in 
vitro α-glucosidase and DPP-IV inhibitory activities. 
 
Ocimum sanctum L. (Lamiaceae) 
Ocimum tenuiflorum (Ocimum sanctum) is 
commonly known as Thulasi/Tulsi in India. In the 
Indian subcontinent, fresh leaves of this plant are used 
for the treatment of cough, cold, abdominal pain, skin 
diseases, arthritis, painful eye diseases, measles, and 
diarrhoea. The preclinical evaluation on various 
extracts of different parts of O. sanctum shows anti-
fertility, anti-cancer, anti-diabetic, anti-fungal, 
hepatoprotective and cardioprotective actions. 
Methanolic extract of O. sanctum possesses good 
DPP-IV inhibition activity with % inhibition 
66.81%29.  
 
Pilea microphylla (L.) Liebm. (Urticaceae) 
It is commonly known as Gunpowder Plant. It is a 
small, perennial herb. Pilea microphylla balances the 
insulin level and cures diabetes. The infusion of the 
whole plant acts as a diuretic and promotes urination. 
P. microphylla inhibits dipeptidyl peptidase IV  
(DPP-IV) in vitro with an IC50 of 520.4±15.4 g/mL31. 
It is also useful in labour pain and a good remedy to 
cure infertility. 
 
Psidium guajava L. (Myrtaceae) 
Guava leaves serve as popular and traditional 
medicine. It was originally grown from the tropic belt 
countries of Asia and Africa belongs to the Myrtaceae 
family. The main effects for guava extracts are 
sedative, anti-diarrheic, anticestodals, analgesic, anti-
inflammatory, anti-microbial and hepatoprotective. 
The ethanolic leaves extract of Psidium guajava 
possess significant inhibition of DPP-IV enzyme, with 
an IC50 value of 380 μg/mL32. Flavonol glycosides 
isolated from the guava leaves potentially shows 
DPP-IV inhibition activity. 
 
Pterocarpus marsupium Roxb. (Leguminosae) 
It is also known as Malabar kino or Bijasar. It is a 
large tree common to the mixed deciduous forests 
central and Peninsular India. Pterocarpus marsupium 
Roxb. is also used in Indian folk-lore medicine  
for the treatment of diabetes and controls  
diabetes in experimental animals. P. marsupium 
inhibits DPP-IV potently with IC50 values of 
273.73±2.96 µg/mL25. 
 
Punica granatum L. (Leguminosae) 
It is also known as Pomegranate, fruit-bearing 
shrub belong to the family Leguminosae. Research by 
Xinjiang has proved that all three plant extracts i.e 
Trigonella foenum-graecum, (Leguminosae), Cicer 
arietinum, (Leguminosae) and Punica Granatum 
(Leguminosae) has potent inhibition effects on DPP-
IV, with IC50 values of 0.03, 0.09, and 0.19 mg/mL, 
respectively22. 
 
Schisandra chinensis (Turcz.) Baill. (Schisandraceae) 
An antidiabetic Traditional Chinese Medicine 
(TCM) formula, consisted of Schisandra chinensis 
(Schisandraceae), Coptis chinensis (Ranunculaceae), 
Psidium guajava, (Myrtaceae) and Morus alba 
INDIAN J NAT PROD RESOUR, DECEMBER 2019 
 
 
232
(Moraceae), has been studied based on its inhibitory 
activities against α-glucosidase, DPP-IV and 
advanced glycation end products that shows good 
inhibitory actions on DPP-IV22.  
 
Terminalia arjuna (Roxb. ex DC.) Wight & Arn. 
(Combretaceae) 
It is commonly known as Arjuna and is widely 
used in Indian system of medicine. It is basically used 
as cardioprotective, hypotensive, hypolipidemic and 
wound healing activity. Extract of Terminalia arjuna 
exhibited good DPP-IV inhibition activity with the 
highest percentage of DPP-IV inhibition 83.39±7.58%23. 
 
Tinospora crispa (L.) Hook. f. & Thomson (Menispermaceae) 
It is a deciduous climbing shrub which has stems 
up to 15 metres long. Tinospora crispa is a medicinal 
plant used to treat diabetes, by decreasing serum 
glucose level in diabetic rats and the hypoglycemic 
effect was surely due to its insulinotropic activity. T. 
crispa also increased peripheral utilization of glucose 
and inhibited hepatic glucose release33. 
 
Trigonella foenum graceum L. (Leguminosae) 
It is also known as fenugreek, commonly known as 
methi, popular traditional medicinal herb in  
Bangladesh, possesses various biological activities and 
pharmacological functions. Trigonella foenum-graecum 
seeds are also used in high cholesterol, inflammation 
and gastrointestinal ailments. Soraya Riyanti et al. 
investigated many different Indonesian plants and the 
inhibitory percentage of T. foenum graceum extract 
was found to be 71.29±0.33%33 and its IC50 value was 
calculated as 0.03 mg/mL22. 
 
Urena lobata L. (Malvaceae) 
It is also known as caesarwood mainly found in 
Indonesia and is used to cure many diseases. 
Traditionally, Nigerian people used Urena lobata to 
treat diabetes mellitus. The ethanolic and water 
extract of U. lobata leaves shows significant in vitro 
DPP-IV inhibition activity with the IC50 values of 1 
654.64 and 6 489.88 mg/mL, respectively34.  
 
Withania somnifera (L.) Dunal (Solanaceae) 
It is also known as Indian ginseng (Ashwagandha). 
It grows in dry parts of sub-tropical regions. 
Rajasthan, Punjab, Haryana, Uttar Pradesh, Gujarat, 
Maharashtra and Madhya Pradesh are the major 
Ashwagandha producing states of India. Methanolic 
extract of the matured root of Withania somnifera 
exhibits very good DPP-IV inhibitory activity35. 
Catechin is the main constituent of W. somnifera also 
shows good DPP-IV inhibitory action. 
 
Natural phytoconstituents showing DPP-IV 
Inhibition activity 
In recent years, with the rapid progress of new 
technology and the increased research on natural 
DPP-IV inhibitors, lots of plants, their extracts and 
their active chemical constituents (Table 3) has been 
found with powerful inhibitory effects against DPP-
IV, which will give us valuable leads to study safe 
DPP-IV inhibitors. Here, in this review, the natural 
DPP-IV inhibitors discovered over the last few years 
are summarized and categorized according to their 
chemical structures (Fig. 2). 
 
Alkaloids 
Guasch et al. have predicted 12 potential DPP-IV 
inhibitors from 12 different plant extracts that have 
the potential for antidiabetic activity. Nine molecules 
were selected for in vitro bioassay, out of which seven 
compounds were identical having DPP-IV activity 
with IC50 values less than 1.00 mM. The other two 
compounds had no results due to their poor 
solubilities, the results have shown that Virtual 
screening process is a highly efficient approach for 
discovering DPP-IV inhibitors from natural 
products36. 
Berberine is the main isolated compound from  
the Chinese herb Coptis chinensis French. 
(Ranunculaceae), It mainly shows the potent DPP-IV 
inhibitory activity with the in-vitro bioassays (IC50 
value = 13.3 µM)37. 
 
Glycosides 
Kalhotra et al. carried out molecular docking of 
novel chrysin molecules and found that malvidin is 
well-known to inhibit DPP-IV enzyme along with 
other natural products like Hispidulin, Luteolin, 
Apigenin, Hesperetin, Naringenin, Kaempferol, 
Genistein, cyanidin, flavone, Cyanidin-3-glucoside 
and Reserveratol38.  
Bo-Ram Kim, Hyo Young Kim et al., isolated four 
compounds (kaempferol- 3-O-β- gulcopyranosyl-
(1→2)-β-galactopyranosyl-7-O-α-rhamnopyranoside, 
kaempferol-3- O-β-gulcopyranosyl-(1→2)- [α-
rhamnopyranosyl (1→6)]-β-galactopyranosyl-7-O- α-
rhamnopyranoside, and robinin (kaempferol-3-O-α-
rhamnosyl (1→6)-O-β-galactopyranoside- 7-O-α-
rhamnopyranoside and kaempferol) from the seeds of 
Lens culinaris Medikus (Fabaceae) and tested for 
SHARMA et al.: DPP-IV INHIBITORS FROM NATURAL SOURCES 
 
 
233
their DPP-IV–inhibitory activity. Their DPP-IV 
inhibition activities were reported as 27.89±1.29, 
36.52±0.78, 37.01±1.40, and 51.9±4.83 µM, 
respectively39. 
Flavonoids 
Fan J et al. isolated sixteen phenolic compounds 
from the citrus, berry, grape and soybean. 
Anthocyanin analysis was carried out followed by  
 
 
Table No. 3 — List of active constituents showing DPP-IV inhibition 
S.  
No. 
Active principles Biological source Family Plant part used Enzyme inhibitory 
activity (IC50) 
Reference  
 
1 Alkaloids 
 Berberine Coptis chinensis Franch. Ranunculaceae Stem and root 14.4 µg/mL 37 
2 Glycosides 
 Malvidin Anagallis monelli (L.) U. 
Manns & Anderb  
Primulaceae Aerial parts 1.41 µM 38 
 Kaempferol- 3-O-β- 
gulcopyranosyl-(1→2)-β-
galactopyranosyl-7-Oα-
rhamnopyranoside 
Lens culinaris Medikus Leguminosae Seeds  27.89 µM 39 
 Kaempferol-3- O-β-
gulcopyranosyl-(1→2)-[α-
rhamnopyranosyl(1→6)]-β-
galactopyranosyl-7-O- α-
rhamnopyranoside 
Lens culinaris Medikus Leguminosae Seeds  36.52 µM 39 
 Robinin Lens culinaris Medikus Leguminosae Seeds  37.01 µM 39 
 Kaempferol Lens culinaris Medikus Leguminosae Seeds  51.9 µM 39 
3 Flavonoids and Phenols 
 Apigenin Acacia auriculiformis A. 
Cunn. ex Benth. 
Fabaceae Stem and pods  0.14 µM 40 
 Caffeic acid Coffea arabica L. Rubiaceae Leaves  3.37 µM 40 
 Cirsimaritin Rosamarinus officinalis L. Lamiaceae Leaves 0.43 µM 41 
 Cyanidin Rubus fruticosus L. Rosaceae Fruits 1.41 µM 40 
 Cyanidin-3-glucoside Vaccinum corymbosum L. Ericaceae Fruits 125.1 µM 42 
 Emodin Rheum palmatum L. Polygonaceae Leaves 5.76 µM 43 
 Epigallocatechin gallate Camellia sinensis (L.) 
Kuntze 
Theaceae Leaves 10.21 µM 40 
 Eriocitrin Citrus limon (L.) Osbeck Rutaceae Fruits 10.36 µM 40 
 Eriocdictyol Lippia graveolens Kunth Verbenaceae Leaves 10.9 µM 41 
 Gallic acid Camellia sinensis (L.) 
Kuntze 
Theaceae Leaves 4.65 µM 40 
 Genistein Psoralea corylifolia L. Fabaceae Leaves 0.48 µM 40 
 Hesperetin Citrus aurantium L. Rutaceae Fruits 0.28 µM 40 
 Hispidulin Origanum majorana L. Lamiaceae - 0.49 µM 41 
 Luteolin Brassica oleracea L. Brassicaceae Leaves 0.12 µM 40 
 Naringenin Citrus maxima Merr. Rutaceae Fruit 0.24 µM 40 
 Quercetin Quercus alba L. Fagaceae - 2.92 µM 40 
 Rosmarinic acid Rosamarinus officinalis L. Lamiaceae - 14.1 µM 41 
 Rutin Fagopyrum esculentum 
Moench 
Polygonaceae Leaves  485 µM 44 
 Isoquercitin Pilea microphylla (L.) 
Liebm. 
Urticaceae Leaves  96.8 µM 45 
4 Terpenoids 
 Rebaudioside A Stevia rebaudiana (Bertoni) Asteraceae Leaves  - 47 
 Stevioside Stevia rebaudiana (Bertoni)  Asteraceae Leaves - 47 
 Lupeol Hedera nepalensis K. Koch Araliaceae Aerial parts 31.6 µM 26 
5 Phenol and Stilbenoid  
 Hopeaphenol Vitis thunbergii var. 
taiwaniana 
Vitaceae Stem and leaves 401 µM 48 
 Vitisin A Vitis thunbergii var. 
taiwaniana 
Vitaceae Stem and leaves 90.75 µM 48 
 Vitisin B Vitis thunbergii var. 
taiwaniana 
Vitaceae Stem and leaves 15.3 µM 48 
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DPP-IV inhibition assay where blank contained the 
vehicle only and positive control contained the 
vehicle and purified DPP-IV enzyme. The results 
were compared with the positive control diprotin A 
(Ile-Pro-Ile, IC50, 4.21±2.01 μM) which showed that 
these varieties of phenolic compounds had DPP-IV 
inhibitory activities in vitro with different IC50 
values40, like apigenin (IC50 = 0.14±0.02 μM), caffeic 
 
 
 
 
 
Fig. 2 — Structures of active constituent showing DPP-IV inhibition activity 
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acid (IC50 = 3.37±0.14 μM), cyanidin (IC50 = 
1.41±0.25 μM), epigallocatechin gallate (IC50 =  
10.21±0.75 μM), eriocitrin (IC50= 10.36±0.09 μM), 
gallic acid (IC50 = 4.65±0.99 μM), genistein (IC50 = 
0.48±0.04 μM), hesperetin (IC50 = 0.28±0.07 μM), 
luteolin (IC50 = 0.12±0.01 μM), naringenin (IC50 = 
0.24±0.03 μM), quercetin (IC50 = 2.92±0.68 μM). 
Insilico and molecular docking were also performed 
on these phenolic compounds40.  
Six main active constituents from greenhouse-
grown Mexican oregano (Lippia graveolens Kunth ) 
(Lamiaceae) and Rosemary (Rosmarinus officinalis L.) 
(Lamiaceae) in vitro assay shows that these 
constituents exhibits potent DPP-IV inhibitory 
activities41 and IC50 values compare with sitagliptin as 
positive control (IC50 = 0.06±0.03 μM), eriocdictyol 
(IC50 = 10.9±0.4 μM), hispidulin (IC50 = 0.49±0.1 
μM), cirsimaritin (IC50 = 0.43±0.07 μM) and 
rosamarinic acid (IC50 = 14.1±1.7 μM), naringenin 
(IC50 = 2.5±0.3 μM), while carnosol (IC50 > 100 μM) 
is a weaker inhibitor41. 
Casedas G et al. discussed the potential role of the 
anthocyanin (Cyanidin 3-O-Glucoside) as therapeutic 
candidate to treat chronic diseases like diabetes by 
inhibiting DPP-IV enzyme. It was evaluated that 
cyanidin 3-O-glucoside was able to inhibit α-GLU 
(IC50 = 479.8 μM) and DPP-IV (IC50 = 125.1 μM) 
enzyme respectively42. 
Emodin, which is isolated from the Rheum palmatum 
L. inhibit DPP-IV activity in vitro without inhibiting 
DPP-VIII or DPP-IX. The IC50 value (5.76 µM) shows 
the potency of emodin as DPP-IV inhibitor43. 
Citrus flavonoids show significant DPP-IV 
inhibitory activities in comparison with gliptins IC50 
values of 0.684 µM (sitagliptin), 0.707 µM 
(saxagliptin) and 2.286 µM (vildagliptin). In vitro 
studies proves that rutin is the most potent inhibitor of 
DPP-IV with an IC50 value of 485 µM44. 
Isoquercitrin45, is the main constituent isolate from 
the apocynum and folium mori, it is widely existing in 
medicinal plants, food and beverage, fruits and 
vegetables and shows antioxidant, anti-inflammatory, 
antidepressant, antihypertensive, and lipid-lowering 
activities. In vitro activities of isoquercetin show its 
potency as a DPP-IV inhibitor (IC50 = 96.8 µM). 
Naringin is the main active constituent isolate from 
peels of Citrus maxima Merr. and Citrus aurantium L. 
(Rutaceae), shows significant DPP-IV inhibitory 
activity. The in vivo study shows that naringin has 
strong activity against DPP-IV46. 
Terpenoids and steroids 
Rebaudioside A and stevioside, are the two main 
sesquiterpene glycoside identifies from the Stevia 
rebaudiana (Bertoni) (Asteraceae), has potential 
DPP-IV inhibitory activities by molecular docking47.  
 
Phenols and stilbenoid 
Three main compounds from the Vitis thunbergii 
var. taiwaniana showed potent DPP-IV inhibitory 
activity. Ethanol extracts from the stems and  
leaves of plant possess DPP-IV inhibition activity. 
(+)-Hopeaphenol, (+)-vitisin A, and (−)-vitisin B are 
the main constituents which has good results against 
α-glucosidase and DPP-IV with IC50 values 
401,90.75, and 15.3 μM respectively48. 
 
Conclusion 
In recent years, the enzyme DPP-IV has become an 
important drug target for diabetes therapy and  
DPP-IV inhibitors become a popular remedy for it. 
However, some chemically synthesized compounds 
are commercially available. Molecular docking is also 
one of the important tools in finding the potential or 
advancement of DPP-IV inhibitors from natural 
products. The in vivo and in vitro experiments from 
current literature suggested the potential of medicinal 
plants, their extracts and their active chemical 
constituents in inhibiting DPP-IV activity. 
Although, nature is a rich source of medicinal 
plants that have been used to treat diabetes mellitus 
from ages. Therefore, the discovery of natural  
DPP-IV inhibitors may suggest a new chance or a 
new idea for developing newer medications. The 
reported studies will significantly enhance research to 
discover new DPP-IV inhibitors from natural products 
by using modern techniques. It is believed that this 
review will capture the attention of other research 
groups to develop newer natural DPP-IV inhibitors 
that could be better diabetic agents in terms of safety 
and efficiency. 
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